2023-2029 Global Chronic Pain Topical Analgesics Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 156 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

This report aims to provide a comprehensive study of the global market for Chronic Pain Topical Analgesics. Report Highlights:
(1) Global Chronic Pain Topical Analgesics market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Chronic Pain Topical Analgesics market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Chronic Pain Topical Analgesics market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Chronic Pain Topical Analgesics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Chronic Pain Topical Analgesics segment by type and by application and regional segment by type and by application.
(6) Chronic Pain Topical Analgesics industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Chronic Pain Topical Analgesics should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Chronic Pain Topical Analgesics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Chronic Pain Topical Analgesics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Analgesic Creams segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Muscle Pain has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Chronic Pain Topical Analgesics include Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson and GSK, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Analgesic Creams
Analgesic Sprays
Pain Relief Patches
Market segment by application, can be divided into
Muscle Pain
Arthritis Pain
Market segment by players, this report covers
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Hisamitsu
Mylan
Lingrui
Teikoku Seiyaku
The Pure Source
Mercury Healthcare

1 Market Overview
1.1 Product Overview and Scope of Chronic Pain Topical Analgesics
1.2 Global Chronic Pain Topical Analgesics Market Size and Forecast
1.3 China Chronic Pain Topical Analgesics Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Chronic Pain Topical Analgesics Share in Global Market, 2018-2029
1.4.2 Chronic Pain Topical Analgesics Market Size: China VS Global, 2018-2029
1.5 Chronic Pain Topical Analgesics Market Dynamics
1.5.1 Chronic Pain Topical Analgesics Market Drivers
1.5.2 Chronic Pain Topical Analgesics Market Restraints
1.5.3 Chronic Pain Topical Analgesics Industry Trends
1.5.4 Chronic Pain Topical Analgesics Industry Policy
2 Global Competitive Situation by Company
2.1 Global Chronic Pain Topical Analgesics Revenue by Company (2018-2023)
2.2 Global Chronic Pain Topical Analgesics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Chronic Pain Topical Analgesics Concentration Ratio
2.4 Global Chronic Pain Topical Analgesics Mergers & Acquisitions, Expansion Plans
2.5 Global Chronic Pain Topical Analgesics Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Chronic Pain Topical Analgesics Revenue by Company (2018-2023)
3.2 China Chronic Pain Topical Analgesics Chronic Pain Topical Analgesics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Chronic Pain Topical Analgesics, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Chronic Pain Topical Analgesics Industry Chain
4.2 Chronic Pain Topical Analgesics Upstream Analysis
4.3 Chronic Pain Topical Analgesics Midstream Analysis
4.4 Chronic Pain Topical Analgesics Downstream Analysis
5 Sights by Type
5.1 Chronic Pain Topical Analgesics Classification
5.1.1 Analgesic Creams
5.1.2 Analgesic Sprays
5.1.3 Pain Relief Patches
5.2 By Type, Global Chronic Pain Topical Analgesics Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Chronic Pain Topical Analgesics Revenue, 2018-2029
6 Sights by Application
6.1 Chronic Pain Topical Analgesics Segment by Application
6.1.1 Muscle Pain
6.1.2 Arthritis Pain
6.2 By Application, Global Chronic Pain Topical Analgesics Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Chronic Pain Topical Analgesics Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Chronic Pain Topical Analgesics Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Chronic Pain Topical Analgesics Market Size, 2018-2029
7.3 North America
7.3.1 North America Chronic Pain Topical Analgesics Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Chronic Pain Topical Analgesics Market Size Market Share
7.4 Europe
7.4.1 Europe Chronic Pain Topical Analgesics Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Chronic Pain Topical Analgesics Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Chronic Pain Topical Analgesics Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Chronic Pain Topical Analgesics Market Size Market Share
7.6 South America
7.6.1 South America Chronic Pain Topical Analgesics Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Chronic Pain Topical Analgesics Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Chronic Pain Topical Analgesics Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Chronic Pain Topical Analgesics Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Chronic Pain Topical Analgesics Market Size, 2018-2029
8.3.2 By Company, U.S. Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Chronic Pain Topical Analgesics Market Size, 2018-2029
8.4.2 By Company, Europe Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Chronic Pain Topical Analgesics Market Size, 2018-2029
8.5.2 By Company, China Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.5.3 By Type, China Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Chronic Pain Topical Analgesics Market Size, 2018-2029
8.6.2 By Company, Japan Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Chronic Pain Topical Analgesics Market Size, 2018-2029
8.7.2 By Company, South Korea Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Chronic Pain Topical Analgesics Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Chronic Pain Topical Analgesics Market Size, 2018-2029
8.9.2 By Company, India Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.9.3 By Type, India Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Chronic Pain Topical Analgesics Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Roche (Genentech)
9.1.1 Roche (Genentech) Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche (Genentech) Company Profile and Main Business
9.1.3 Roche (Genentech) Chronic Pain Topical Analgesics Models, Specifications and Application
9.1.4 Roche (Genentech) Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.1.5 Roche (Genentech) Recent Developments
9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Chronic Pain Topical Analgesics Models, Specifications and Application
9.2.4 Amgen Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments
9.3 B-MS
9.3.1 B-MS Company Information, Head Office, Market Area and Industry Position
9.3.2 B-MS Company Profile and Main Business
9.3.3 B-MS Chronic Pain Topical Analgesics Models, Specifications and Application
9.3.4 B-MS Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.3.5 B-MS Recent Developments
9.4 Merck
9.4.1 Merck Company Information, Head Office, Market Area and Industry Position
9.4.2 Merck Company Profile and Main Business
9.4.3 Merck Chronic Pain Topical Analgesics Models, Specifications and Application
9.4.4 Merck Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.4.5 Merck Recent Developments
9.5 Pfizer
9.5.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.5.2 Pfizer Company Profile and Main Business
9.5.3 Pfizer Chronic Pain Topical Analgesics Models, Specifications and Application
9.5.4 Pfizer Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.6.2 Novartis Company Profile and Main Business
9.6.3 Novartis Chronic Pain Topical Analgesics Models, Specifications and Application
9.6.4 Novartis Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.6.5 Novartis Recent Developments
9.7 Eli Lilly and Company
9.7.1 Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position
9.7.2 Eli Lilly and Company Company Profile and Main Business
9.7.3 Eli Lilly and Company Chronic Pain Topical Analgesics Models, Specifications and Application
9.7.4 Eli Lilly and Company Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.7.5 Eli Lilly and Company Recent Developments
9.8 Johnson & Johnson
9.8.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.8.2 Johnson & Johnson Company Profile and Main Business
9.8.3 Johnson & Johnson Chronic Pain Topical Analgesics Models, Specifications and Application
9.8.4 Johnson & Johnson Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.8.5 Johnson & Johnson Recent Developments
9.9 GSK
9.9.1 GSK Company Information, Head Office, Market Area and Industry Position
9.9.2 GSK Company Profile and Main Business
9.9.3 GSK Chronic Pain Topical Analgesics Models, Specifications and Application
9.9.4 GSK Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.9.5 GSK Recent Developments
9.10 Sanofi
9.10.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.10.2 Sanofi Company Profile and Main Business
9.10.3 Sanofi Chronic Pain Topical Analgesics Models, Specifications and Application
9.10.4 Sanofi Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.10.5 Sanofi Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
9.11.2 Boehringer Ingelheim Company Profile and Main Business
9.11.3 Boehringer Ingelheim Chronic Pain Topical Analgesics Models, Specifications and Application
9.11.4 Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.11.5 Boehringer Ingelheim Recent Developments
9.12 Zhejiang Jiuzhou Pharmaceutical
9.12.1 Zhejiang Jiuzhou Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.12.2 Zhejiang Jiuzhou Pharmaceutical Company Profile and Main Business
9.12.3 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Models, Specifications and Application
9.12.4 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
9.13 Hisamitsu
9.13.1 Hisamitsu Company Information, Head Office, Market Area and Industry Position
9.13.2 Hisamitsu Company Profile and Main Business
9.13.3 Hisamitsu Chronic Pain Topical Analgesics Models, Specifications and Application
9.13.4 Hisamitsu Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.13.5 Hisamitsu Recent Developments
9.14 Mylan
9.14.1 Mylan Company Information, Head Office, Market Area and Industry Position
9.14.2 Mylan Company Profile and Main Business
9.14.3 Mylan Chronic Pain Topical Analgesics Models, Specifications and Application
9.14.4 Mylan Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.14.5 Mylan Recent Developments
9.15 Lingrui
9.15.1 Lingrui Company Information, Head Office, Market Area and Industry Position
9.15.2 Lingrui Company Profile and Main Business
9.15.3 Lingrui Chronic Pain Topical Analgesics Models, Specifications and Application
9.15.4 Lingrui Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.15.5 Lingrui Recent Developments
9.16 Teikoku Seiyaku
9.16.1 Teikoku Seiyaku Company Information, Head Office, Market Area and Industry Position
9.16.2 Teikoku Seiyaku Company Profile and Main Business
9.16.3 Teikoku Seiyaku Chronic Pain Topical Analgesics Models, Specifications and Application
9.16.4 Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.16.5 Teikoku Seiyaku Recent Developments
9.17 The Pure Source
9.17.1 The Pure Source Company Information, Head Office, Market Area and Industry Position
9.17.2 The Pure Source Company Profile and Main Business
9.17.3 The Pure Source Chronic Pain Topical Analgesics Models, Specifications and Application
9.17.4 The Pure Source Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.17.5 The Pure Source Recent Developments
9.18 Mercury Healthcare
9.18.1 Mercury Healthcare Company Information, Head Office, Market Area and Industry Position
9.18.2 Mercury Healthcare Company Profile and Main Business
9.18.3 Mercury Healthcare Chronic Pain Topical Analgesics Models, Specifications and Application
9.18.4 Mercury Healthcare Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
9.18.5 Mercury Healthcare Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

Tables and Figures

Table 1. Chronic Pain Topical Analgesics Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Chronic Pain Topical Analgesics Market Restraints
Table 3. Chronic Pain Topical Analgesics Market Trends
Table 4. Chronic Pain Topical Analgesics Industry Policy
Table 5. Global Chronic Pain Topical Analgesics Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Chronic Pain Topical Analgesics Revenue Market Share by Company (2018-2023)
Table 7. Global Chronic Pain Topical Analgesics Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Chronic Pain Topical Analgesics Mergers & Acquisitions, Expansion Plans
Table 9. Global Chronic Pain Topical Analgesics Manufacturers Product Type
Table 10. China Chronic Pain Topical Analgesics Revenue by Company (2018-2023) & (US$ million)
Table 11. China Chronic Pain Topical Analgesics Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Chronic Pain Topical Analgesics Upstream (Raw Materials)
Table 13. Global Chronic Pain Topical Analgesics Typical Customers
Table 14. Chronic Pain Topical Analgesics Typical Distributors
Table 15. By Type, Global Chronic Pain Topical Analgesics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Chronic Pain Topical Analgesics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Chronic Pain Topical Analgesics Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Chronic Pain Topical Analgesics Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Chronic Pain Topical Analgesics Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Chronic Pain Topical Analgesics Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Chronic Pain Topical Analgesics Revenue Market Share, 2018-2029
Table 22. Roche (Genentech) Company Information, Head Office, Market Area and Industry Position
Table 23. Roche (Genentech) Company Profile and Main Business
Table 24. Roche (Genentech) Chronic Pain Topical Analgesics Models, Specifications and Application
Table 25. Roche (Genentech) Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 26. Roche (Genentech) Recent Developments
Table 27. Amgen Company Information, Head Office, Market Area and Industry Position
Table 28. Amgen Company Profile and Main Business
Table 29. Amgen Chronic Pain Topical Analgesics Models, Specifications and Application
Table 30. Amgen Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 31. Amgen Recent Developments
Table 32. B-MS Company Information, Head Office, Market Area and Industry Position
Table 33. B-MS Company Profile and Main Business
Table 34. B-MS Chronic Pain Topical Analgesics Models, Specifications and Application
Table 35. B-MS Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 36. B-MS Recent Developments
Table 37. Merck Company Information, Head Office, Market Area and Industry Position
Table 38. Merck Company Profile and Main Business
Table 39. Merck Chronic Pain Topical Analgesics Models, Specifications and Application
Table 40. Merck Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 41. Merck Recent Developments
Table 42. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 43. Pfizer Company Profile and Main Business
Table 44. Pfizer Chronic Pain Topical Analgesics Models, Specifications and Application
Table 45. Pfizer Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 46. Pfizer Recent Developments
Table 47. Novartis Company Information, Head Office, Market Area and Industry Position
Table 48. Novartis Company Profile and Main Business
Table 49. Novartis Chronic Pain Topical Analgesics Models, Specifications and Application
Table 50. Novartis Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 51. Novartis Recent Developments
Table 52. Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position
Table 53. Eli Lilly and Company Company Profile and Main Business
Table 54. Eli Lilly and Company Chronic Pain Topical Analgesics Models, Specifications and Application
Table 55. Eli Lilly and Company Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 56. Eli Lilly and Company Recent Developments
Table 57. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 58. Johnson & Johnson Company Profile and Main Business
Table 59. Johnson & Johnson Chronic Pain Topical Analgesics Models, Specifications and Application
Table 60. Johnson & Johnson Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 61. Johnson & Johnson Recent Developments
Table 62. GSK Company Information, Head Office, Market Area and Industry Position
Table 63. GSK Company Profile and Main Business
Table 64. GSK Chronic Pain Topical Analgesics Models, Specifications and Application
Table 65. GSK Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 66. GSK Recent Developments
Table 67. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 68. Sanofi Company Profile and Main Business
Table 69. Sanofi Chronic Pain Topical Analgesics Models, Specifications and Application
Table 70. Sanofi Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 71. Sanofi Recent Developments
Table 72. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 73. Boehringer Ingelheim Company Profile and Main Business
Table 74. Boehringer Ingelheim Chronic Pain Topical Analgesics Models, Specifications and Application
Table 75. Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 76. Boehringer Ingelheim Recent Developments
Table 77. Zhejiang Jiuzhou Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 78. Zhejiang Jiuzhou Pharmaceutical Company Profile and Main Business
Table 79. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Models, Specifications and Application
Table 80. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 81. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 82. Hisamitsu Company Information, Head Office, Market Area and Industry Position
Table 83. Hisamitsu Company Profile and Main Business
Table 84. Hisamitsu Chronic Pain Topical Analgesics Models, Specifications and Application
Table 85. Hisamitsu Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 86. Hisamitsu Recent Developments
Table 87. Mylan Company Information, Head Office, Market Area and Industry Position
Table 88. Mylan Company Profile and Main Business
Table 89. Mylan Chronic Pain Topical Analgesics Models, Specifications and Application
Table 90. Mylan Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 91. Mylan Recent Developments
Table 92. Lingrui Company Information, Head Office, Market Area and Industry Position
Table 93. Lingrui Company Profile and Main Business
Table 94. Lingrui Chronic Pain Topical Analgesics Models, Specifications and Application
Table 95. Lingrui Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 96. Lingrui Recent Developments
Table 97. Teikoku Seiyaku Company Information, Head Office, Market Area and Industry Position
Table 98. Teikoku Seiyaku Company Profile and Main Business
Table 99. Teikoku Seiyaku Chronic Pain Topical Analgesics Models, Specifications and Application
Table 100. Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 101. Teikoku Seiyaku Recent Developments
Table 102. The Pure Source Company Information, Head Office, Market Area and Industry Position
Table 103. The Pure Source Company Profile and Main Business
Table 104. The Pure Source Chronic Pain Topical Analgesics Models, Specifications and Application
Table 105. The Pure Source Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 106. The Pure Source Recent Developments
Table 107. Mercury Healthcare Company Information, Head Office, Market Area and Industry Position
Table 108. Mercury Healthcare Company Profile and Main Business
Table 109. Mercury Healthcare Chronic Pain Topical Analgesics Models, Specifications and Application
Table 110. Mercury Healthcare Chronic Pain Topical Analgesics Revenue and Gross Margin, 2018-2023
Table 111. Mercury Healthcare Recent Developments
List of Figure
Figure 1. Chronic Pain Topical Analgesics Picture
Figure 2. Global Chronic Pain Topical Analgesics Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Chronic Pain Topical Analgesics Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Chronic Pain Topical Analgesics Market Share of Global
Figure 5. Global Chronic Pain Topical Analgesics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Chronic Pain Topical Analgesics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Chronic Pain Topical Analgesics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Chronic Pain Topical Analgesics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Chronic Pain Topical Analgesics Industry Chain
Figure 10. Analgesic Creams
Figure 11. Analgesic Sprays
Figure 12. Pain Relief Patches
Figure 13. By Type, Global Chronic Pain Topical Analgesics Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global Chronic Pain Topical Analgesics Revenue Market Share, 2018-2029
Figure 15. Muscle Pain
Figure 16. Arthritis Pain
Figure 17. By Application, Global Chronic Pain Topical Analgesics Revenue, 2018-2029, US$ Million
Figure 18. By Application, Global Chronic Pain Topical Analgesics Revenue Market Share, 2018-2029
Figure 19. By Region, Global Chronic Pain Topical Analgesics Revenue Market Share, 2018-2029
Figure 20. North America Chronic Pain Topical Analgesics Revenue & Forecasts, 2018-2029, US$ Million
Figure 21. By Country, North America Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
Figure 22. Europe Chronic Pain Topical Analgesics Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, Europe Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
Figure 24. Asia Pacific Chronic Pain Topical Analgesics Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country/Region, Asia Pacific Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
Figure 26. South America Chronic Pain Topical Analgesics Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, South America Chronic Pain Topical Analgesics Revenue Market Share, 2018-2023
Figure 28. Middle East & Africa Chronic Pain Topical Analgesics Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. U.S. Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 30. By Company, U.S. Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 31. By Type, U.S. Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 33. Europe Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, Europe Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 35. By Type, Europe Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 36. By Application, Europe Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 37. China Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, China Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 39. By Type, China Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 40. By Application, China Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 41. Japan Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, Japan Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 43. By Type, Japan Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 44. By Application, Japan Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 45. South Korea Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, South Korea Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 47. By Type, South Korea Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 49. Southeast Asia Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, Southeast Asia Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 51. By Type, Southeast Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 53. India Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, India Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 55. By Type, India Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 56. By Application, India Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 57. Middle East & Asia Chronic Pain Topical Analgesics Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, Middle East & Asia Chronic Pain Topical Analgesics Market Share, 2018-2023
Figure 59. By Type, Middle East & Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 60. By Application, Middle East & Asia Chronic Pain Topical Analgesics Revenue Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up Approaches
Figure 64. Top-down Approaches



Reason to Buy

  • Current and future of Uncategorized Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Uncategorized Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets